首页 > 最新文献

Blood Pressure最新文献

英文 中文
Evaluation of race-free eGFR equations in individuals of different ethnicity. 不同种族个体中无种族eGFR方程的评价。
IF 2.3 4区 医学 Pub Date : 2025-12-01 Epub Date: 2025-07-22 DOI: 10.1080/08037051.2025.2533456
De-Wei An, Gontse G Mokwatsi, Dong-Yan Zhang, Dries S Martens, Yu-Ling Yu, Babangida S Chori, Augustine N Odili, Ruan Kruger, Lebo F Gafane-Matemane, Justyna Siwy, Agnieszka Latosinska, Harald Mischak, Catharina Mc Mels, Aletta E Schutte, Jean-René M'Buyamba-Kabangu, Tim S Nawrot, Yan Li, Jan A Staessen

Background: Glomerular filtration rate (eGFR) derived from serum creatinine (eGFRcr), cystatin C (eGFRcys), or both (eGFRcr-cys) by race-free equations are recommended staging chronic kidney disease (CKD). The current study aimed to compare these race-free eGFR equations for screening for low-grade CKD in Blacks and non-Blacks and to evaluate their association with mortality.

Methods: Race-free eGFR equations were evaluated in four studies with specific inclusion criteria based on the original research goals: African-PREDICT (341/380 healthy Black/White South Africans), FLEMENGHO (709 White community-dwelling Flemish), NHANES (1760/7931 Black and non-Black adult Americans), and 401 Black African patients hospitalised in Mbuji Mayi, Democratic Republic of Congo. The intraclass correlation coefficient and Bland and Altman statistics were used to assess consistency between eGFR equations and multivariable logistic or Cox regression to evaluate their association with mortality.

Results: Intraindividual discordance between eGFRs was larger in Black than non-Black NHANES and African-PREDICT participants. In NHANES, eGFRcr-cys was greater than eGFRcr, but smaller than eGFRcys, and replacing eGFRcr-cys by eGFRcr moved 25% Blacks and 15% non-Blacks to a higher (worse) eGFR KDIGO stage. In African-PREDICT and FLEMENGO, half of the measured creatinine clearance to eGFR ratios fell outside the expected 1.1-1.2 band. In NHANES, multivariable hazard ratios for total and cardiovascular mortality in relation to CKD grade were all lower than unity for grade-1 CKD and greater than unity for grade ≥3 (p < 0.0001) without any racial difference (0.11≤p ≤ 0.98). These NHANES findings were consistent, if CKD stage was replaced by eGFR and in subgroup analyses. Whereas eGFRcys and eGFRcr-cys refined models, eGFRcr did not.

Conclusions: The NHANES mortality outcomes support the use of eGFRcys and eGFRcr-cys. However, large intraindividual variability between eGFR estimates may lead to KDIGO eGFR stage misclassification and calls for caution in the opportunistic or systematic screening for CKD in asymptomatic individuals with prevention as objective.

背景:肾小球滤过率(eGFR)由血清肌酐(eGFRcr)、胱抑素C (eGFRcys)或两者(eGFRcr-cys)通过无种族方程得出,推荐用于慢性肾脏疾病(CKD)分期。目前的研究旨在比较这些无种族的eGFR方程用于筛查黑人和非黑人的低级别CKD,并评估其与死亡率的关系。方法:根据最初的研究目标,在四项研究中评估无种族的eGFR方程,并制定具体的纳入标准:African- predict(341/380名健康的南非黑人/白人)、FLEMENGHO(709名白人社区居住的佛兰芒人)、NHANES(1760/7931名黑人和非黑人成年美国人)和401名在刚果民主共和国Mbuji Mayi住院的非洲黑人患者。使用类内相关系数和Bland和Altman统计来评估eGFR方程与多变量逻辑回归或Cox回归之间的一致性,以评估其与死亡率的相关性。结果:黑人受试者的egfr个体内差异大于非黑人NHANES和非洲裔predict受试者。在NHANES中,eGFRcr-cys大于eGFRcr,但小于eGFRcys,用eGFRcr代替eGFRcr-cys使25%的黑人和15%的非黑人进入eGFR更高(更差)的KDIGO阶段。在African-PREDICT和FLEMENGO,一半的肌酐清除率与eGFR比值低于预期的1.1-1.2范围。在NHANES中,与CKD分级相关的总死亡率和心血管死亡率的多变量风险比在1级CKD中均小于1,在≥3级CKD中大于1 (p cys和eGFRcr-cys精细模型,eGFRcr没有)。结论:NHANES死亡率结果支持eGFRcys和eGFRcr-cys的使用。然而,eGFR估计值之间的巨大个体差异可能导致KDIGO对eGFR分期的错误分类,并呼吁在无症状个体中以预防为目标的CKD机会性或系统性筛查时要谨慎。
{"title":"Evaluation of race-free eGFR equations in individuals of different ethnicity.","authors":"De-Wei An, Gontse G Mokwatsi, Dong-Yan Zhang, Dries S Martens, Yu-Ling Yu, Babangida S Chori, Augustine N Odili, Ruan Kruger, Lebo F Gafane-Matemane, Justyna Siwy, Agnieszka Latosinska, Harald Mischak, Catharina Mc Mels, Aletta E Schutte, Jean-René M'Buyamba-Kabangu, Tim S Nawrot, Yan Li, Jan A Staessen","doi":"10.1080/08037051.2025.2533456","DOIUrl":"10.1080/08037051.2025.2533456","url":null,"abstract":"<p><strong>Background: </strong>Glomerular filtration rate (eGFR) derived from serum creatinine (eGFR<sub>cr</sub>), cystatin C (eGFR<sub>cys</sub>), or both (eGFR<sub>cr-cys</sub>) by race-free equations are recommended staging chronic kidney disease (CKD). The current study aimed to compare these race-free eGFR equations for screening for low-grade CKD in Blacks and non-Blacks and to evaluate their association with mortality.</p><p><strong>Methods: </strong>Race-free eGFR equations were evaluated in four studies with specific inclusion criteria based on the original research goals: African-PREDICT (341/380 healthy Black/White South Africans), FLEMENGHO (709 White community-dwelling Flemish), NHANES (1760/7931 Black and non-Black adult Americans), and 401 Black African patients hospitalised in Mbuji Mayi, Democratic Republic of Congo. The intraclass correlation coefficient and Bland and Altman statistics were used to assess consistency between eGFR equations and multivariable logistic or Cox regression to evaluate their association with mortality.</p><p><strong>Results: </strong>Intraindividual discordance between eGFRs was larger in Black than non-Black NHANES and African-PREDICT participants. In NHANES, eGFR<sub>cr-cys</sub> was greater than eGFR<sub>cr</sub>, but smaller than eGFR<sub>cys</sub>, and replacing eGFR<sub>cr-cys</sub> by eGFR<sub>cr</sub> moved 25% Blacks and 15% non-Blacks to a higher (worse) eGFR KDIGO stage. In African-PREDICT and FLEMENGO, half of the measured creatinine clearance to eGFR ratios fell outside the expected 1.1-1.2 band. In NHANES, multivariable hazard ratios for total and cardiovascular mortality in relation to CKD grade were all lower than unity for grade-1 CKD and greater than unity for grade ≥3 (<i>p</i> < 0.0001) without any racial difference (0.11≤<i>p</i> ≤ 0.98). These NHANES findings were consistent, if CKD stage was replaced by eGFR and in subgroup analyses. Whereas eGFR<sub>cys</sub> and eGFR<sub>cr-cys</sub> refined models, eGFR<sub>cr</sub> did not.</p><p><strong>Conclusions: </strong>The NHANES mortality outcomes support the use of eGFR<sub>cys</sub> and eGFR<sub>cr-cys</sub>. However, large intraindividual variability between eGFR estimates may lead to KDIGO eGFR stage misclassification and calls for caution in the opportunistic or systematic screening for CKD in asymptomatic individuals with prevention as objective.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2533456"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12315838/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144635993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transportation noise: its cardiovascular effects and their reversibility; a narrative review. 交通噪声对心血管的影响及其可逆性叙述性评论
IF 2.3 4区 医学 Pub Date : 2025-12-01 Epub Date: 2025-09-06 DOI: 10.1080/08037051.2025.2547828
Maryla Kocowska-Trytko, Marek Rajzer

Background: Transportation noise seems to be inherent in modern urban living. However, many studies indicate that it can unfavorably affect human health, especially by influencing the cardiovascular outcome. The large number of people exposed to noise in the European Union becomes relevant to public health. This requires the creation and implementation of laws that aim to reduce the burden of adverse environmental factors, such as noise, air pollution, and light pollution. Road noise, aircraft, and railway noise have been shown to increase the incidence of hypertension, myocardial infarction, and mortality.

Aim and method: This narrative review presents possible mechanisms of adverse effects of noise on the body that lead to increased cardiovascular risk, its potential reversibility, and methods of mitigating noise influence.

Conclusions: Comprehensive multidisciplinary efforts are needed to reduce the impact of noise on Europeans and thereby reduce cardiovascular risk. Authorities, institutions, and healthcare providers play an important role in mitigating noise impact and promoting awareness, emphasizing the importance of continuous monitoring and preventive screening for especially vulnerable people in areas of high exposure..

交通噪音似乎是现代城市生活所固有的。然而,许多研究表明,它会对人体健康产生不利影响,特别是通过影响心血管疾病的结局。在欧盟,大量的人暴露在噪音中,这与公共健康息息相关。这需要制定和实施旨在减少不利环境因素负担的法律,如噪音、空气污染和光污染。道路噪音、飞机和铁路噪音已被证明会增加高血压、心肌梗死和死亡率的发生率。这篇综述提出了可能导致心血管风险增加的对身体的不良影响的机制。在波兰,近年来接触道路交通噪音的人数有所减少,但接触其他来源噪音的人数有所增加。需要综合多学科的努力来减少噪音对欧洲人的影响,从而降低心血管风险。当局、机构和医疗保健提供者在减轻噪音影响和提高认识方面发挥着重要作用,强调持续监测和预防性筛查的重要性,特别是对高暴露地区的弱势群体。
{"title":"Transportation noise: its cardiovascular effects and their reversibility; a narrative review.","authors":"Maryla Kocowska-Trytko, Marek Rajzer","doi":"10.1080/08037051.2025.2547828","DOIUrl":"10.1080/08037051.2025.2547828","url":null,"abstract":"<p><strong>Background: </strong>Transportation noise seems to be inherent in modern urban living. However, many studies indicate that it can unfavorably affect human health, especially by influencing the cardiovascular outcome. The large number of people exposed to noise in the European Union becomes relevant to public health. This requires the creation and implementation of laws that aim to reduce the burden of adverse environmental factors, such as noise, air pollution, and light pollution. Road noise, aircraft, and railway noise have been shown to increase the incidence of hypertension, myocardial infarction, and mortality.</p><p><strong>Aim and method: </strong>This narrative review presents possible mechanisms of adverse effects of noise on the body that lead to increased cardiovascular risk, its potential reversibility, and methods of mitigating noise influence.</p><p><strong>Conclusions: </strong>Comprehensive multidisciplinary efforts are needed to reduce the impact of noise on Europeans and thereby reduce cardiovascular risk. Authorities, institutions, and healthcare providers play an important role in mitigating noise impact and promoting awareness, emphasizing the importance of continuous monitoring and preventive screening for especially vulnerable people in areas of high exposure..</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2547828"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergistic protective effects of remote ischemic postconditioning and enalapril on endothelial dysfunction in spontaneously hypertensive rats via inhibition of oxidative stress-mediated mitochondrial dysfunction. 远程缺血后适应和依那普利通过抑制氧化应激介导的线粒体功能障碍对自发性高血压大鼠内皮功能障碍的协同保护作用。
IF 2.3 4区 医学 Pub Date : 2025-12-01 Epub Date: 2025-11-01 DOI: 10.1080/08037051.2025.2578177
Wanfu Cui, Dan Rong, Peng Qu, Qinglei Zhong, Miaolei Gao, Xinzhu Tong

Purpose: Hypertension-induced vascular injury involves endothelial dysfunction, inflammation, oxidative stress, and mitochondrial damage. While remote ischaemic postconditioning (RIPost) and Enalapril independently offer vascular protection, their synergistic effects remain unclear. This study investigates the combined impact of RIPost and Enalapril on endothelial and mitochondrial function in spontaneously hypertensive rats (SHRs).

Methods: Male SHRs were divided into five groups: untreated SHR, RIPost-treated, Enalapril-treated, combination-treated (RIPost + Enalapril), and MitoQ-treated. Endothelial function was evaluated through histology and vascular relaxation assays. Inflammatory cytokines, oxidative stress indicators, and mitochondrial parameters were assessed via ELISA, Western blotting, and fluorescence-based assays.

Results: SHRs showed elevated blood pressure, endothelial damage, increased inflammatory cytokines (TNF-α, IL-6, IL-1β, MCP-1), oxidative stress (ROS, MDA), and mitochondrial dysfunction (reduced ATP, mtDNA, JC-1; altered MFN2, OPA1, FIS1, DRP1). Both RIPost and Enalapril individually ameliorated these effects, but the combined treatment produced significantly greater improvements. RIPost + Enalapril synergistically reduced blood pressure, restored endothelial integrity, suppressed inflammation and oxidative stress, and normalised mitochondrial dynamics more effectively than either intervention alone.

Conclusion: RIPost combined with Enalapril synergistically attenuates hypertension-induced vascular injury by reducing inflammation and oxidative stress while preserving mitochondrial function. These findings support the combined therapeutic strategy as a promising approach for comprehensive management of hypertensive vascular complications.

目的:高血压引起的血管损伤包括内皮功能障碍、炎症、氧化应激和线粒体损伤。虽然远程缺血后适应(RIPost)和依那普利单独提供血管保护,但它们的协同作用尚不清楚。本研究探讨了RIPost和依那普利联合用药对自发性高血压大鼠内皮和线粒体功能的影响。方法:将男性SHR患者分为5组:未治疗SHR、RIPost治疗组、依那普利治疗组、RIPost +依那普利联合治疗组、mitoq治疗组。内皮功能通过组织学和血管舒张试验评估。通过ELISA、Western blotting和荧光检测评估炎症细胞因子、氧化应激指标和线粒体参数。结果:SHRs表现为血压升高、内皮损伤、炎症因子(TNF-α、IL-6、IL-1β、MCP-1)升高、氧化应激(ROS、MDA)和线粒体功能障碍(ATP、mtDNA、JC-1减少;MFN2、OPA1、FIS1、DRP1改变)。RIPost和依那普利都能单独改善这些效果,但联合治疗效果更显著。与单独干预相比,RIPost +依那普利协同降低血压,恢复内皮完整性,抑制炎症和氧化应激,并使线粒体动力学正常化更有效。结论:RIPost联合依那普利可通过减轻炎症和氧化应激,保护线粒体功能,协同减轻高血压血管损伤。这些发现支持联合治疗策略作为一种有希望的方法来综合管理高血压血管并发症。
{"title":"Synergistic protective effects of remote ischemic postconditioning and enalapril on endothelial dysfunction in spontaneously hypertensive rats via inhibition of oxidative stress-mediated mitochondrial dysfunction.","authors":"Wanfu Cui, Dan Rong, Peng Qu, Qinglei Zhong, Miaolei Gao, Xinzhu Tong","doi":"10.1080/08037051.2025.2578177","DOIUrl":"10.1080/08037051.2025.2578177","url":null,"abstract":"<p><strong>Purpose: </strong>Hypertension-induced vascular injury involves endothelial dysfunction, inflammation, oxidative stress, and mitochondrial damage. While remote ischaemic postconditioning (RIPost) and Enalapril independently offer vascular protection, their synergistic effects remain unclear. This study investigates the combined impact of RIPost and Enalapril on endothelial and mitochondrial function in spontaneously hypertensive rats (SHRs).</p><p><strong>Methods: </strong>Male SHRs were divided into five groups: untreated SHR, RIPost-treated, Enalapril-treated, combination-treated (RIPost + Enalapril), and MitoQ-treated. Endothelial function was evaluated through histology and vascular relaxation assays. Inflammatory cytokines, oxidative stress indicators, and mitochondrial parameters were assessed <i>via</i> ELISA, Western blotting, and fluorescence-based assays.</p><p><strong>Results: </strong>SHRs showed elevated blood pressure, endothelial damage, increased inflammatory cytokines (TNF-α, IL-6, IL-1β, MCP-1), oxidative stress (ROS, MDA), and mitochondrial dysfunction (reduced ATP, mtDNA, JC-1; altered MFN2, OPA1, FIS1, DRP1). Both RIPost and Enalapril individually ameliorated these effects, but the combined treatment produced significantly greater improvements. RIPost + Enalapril synergistically reduced blood pressure, restored endothelial integrity, suppressed inflammation and oxidative stress, and normalised mitochondrial dynamics more effectively than either intervention alone.</p><p><strong>Conclusion: </strong>RIPost combined with Enalapril synergistically attenuates hypertension-induced vascular injury by reducing inflammation and oxidative stress while preserving mitochondrial function. These findings support the combined therapeutic strategy as a promising approach for comprehensive management of hypertensive vascular complications.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2578177"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145336277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
'Pela Saúde de Portugal' - data from a screening on blood pressure. “Pela Saúde de Portugal”——来自血压筛查的数据。
IF 2.3 4区 医学 Pub Date : 2025-12-01 Epub Date: 2025-06-02 DOI: 10.1080/08037051.2025.2506083
Heloisa Ribeiro, Luis Nogueira Silva, Manuel Viana, José Guilherme Assis, Telmo Borges Coelho, João Pedro Patrocínio, Rogério Ferreira, Inês Ambrósio, Rita Palma Féria, Francisca Abecasis, Inês Pinto, Fernando Martos Gonçalves, Rosa de Pinho

Purpose: The Portuguese Society of Hypertension is responsible for the Mission 70/26 Project, a movement that aims to achieve 70% control of hypertensive patients aged 18-65 years old, under Primary Healthcare by 2026. To reach the general population, different activities were done, in this article we will describe one in particular, the campaign called 'Pela Saúde de Portugal'.

Materials and methods: From December 2023 to July 2024, there were nine screenings for hypertension done in eight cities in Portugal. Volunteers were asked about medical history, their weight and blood pressure were assessed and they were informed about Hypertension (HTN) and target organ damage.

Results: 479 screenings were performed. Of the participants, 243 (51%) were female. History of hypertension was reported in 34,7% of them and 32,4% of these were taking medication. There was a significant blood pressure (BP) reduction from the first to the third measurement and both systolic and diastolic BP (mean of the second and third measurements) were higher in hypertensive patients. There were significant BP differences between the cities.

Conclusion: 'Pela Saúde de Portugal' was not a study of the prevalence of hypertension but merely an awareness campaign with HTN screening done all around the country. This type of campaign is important to draw attention to HTN and other risk factors, improving health literacy in this field. The analysis of the volunteer's characteristics is important to design future interventions.

目的:葡萄牙高血压协会负责任务70/26项目,该运动旨在到2026年在初级保健下实现对18-65岁高血压患者70%的控制。为了达到一般人群,开展了不同的活动,在本文中,我们将特别描述一项名为“Pela Saúde de Portugal”的活动。材料与方法:2023年12月至2024年7月,在葡萄牙8个城市进行了9次高血压筛查。研究人员询问了志愿者的病史,评估了他们的体重和血压,并告知他们高血压(HTN)和靶器官损伤。结果:共筛查479例。在参与者中,243人(51%)是女性。其中34.7%的人有高血压病史,32.4%的人正在服药。从第一次测量到第三次测量血压(BP)显著降低,高血压患者的收缩压和舒张压(第二次和第三次测量的平均值)均较高。城市间血压存在显著差异。结论:“Pela Saúde de Portugal”不是一项关于高血压患病率的研究,而仅仅是一项在全国范围内进行HTN筛查的宣传活动。这种类型的运动对于引起人们对HTN和其他风险因素的关注,提高这一领域的卫生知识普及具有重要意义。对志愿者特征的分析对于设计未来的干预措施非常重要。
{"title":"'Pela Saúde de Portugal' - data from a screening on blood pressure.","authors":"Heloisa Ribeiro, Luis Nogueira Silva, Manuel Viana, José Guilherme Assis, Telmo Borges Coelho, João Pedro Patrocínio, Rogério Ferreira, Inês Ambrósio, Rita Palma Féria, Francisca Abecasis, Inês Pinto, Fernando Martos Gonçalves, Rosa de Pinho","doi":"10.1080/08037051.2025.2506083","DOIUrl":"10.1080/08037051.2025.2506083","url":null,"abstract":"<p><strong>Purpose: </strong>The Portuguese Society of Hypertension is responsible for the Mission 70/26 Project, a movement that aims to achieve 70% control of hypertensive patients aged 18-65 years old, under Primary Healthcare by 2026. To reach the general population, different activities were done, in this article we will describe one in particular, the campaign called 'Pela Saúde de Portugal'.</p><p><strong>Materials and methods: </strong>From December 2023 to July 2024, there were nine screenings for hypertension done in eight cities in Portugal. Volunteers were asked about medical history, their weight and blood pressure were assessed and they were informed about Hypertension (HTN) and target organ damage.</p><p><strong>Results: </strong>479 screenings were performed. Of the participants, 243 (51%) were female. History of hypertension was reported in 34,7% of them and 32,4% of these were taking medication. There was a significant blood pressure (BP) reduction from the first to the third measurement and both systolic and diastolic BP (mean of the second and third measurements) were higher in hypertensive patients. There were significant BP differences between the cities.</p><p><strong>Conclusion: </strong>'Pela Saúde de Portugal' was not a study of the prevalence of hypertension but merely an awareness campaign with HTN screening done all around the country. This type of campaign is important to draw attention to HTN and other risk factors, improving health literacy in this field. The analysis of the volunteer's characteristics is important to design future interventions.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"34 1","pages":"2506083"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145740853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A randomised trial comparing usual versus strict home blood pressure control in elderly patients with hypertension: protocol and initial progress. 一项比较常规与严格家庭血压控制的老年高血压患者的随机试验:方案和初步进展。
IF 2.3 4区 医学 Pub Date : 2025-12-01 Epub Date: 2025-03-02 DOI: 10.1080/08037051.2025.2472192
Dong-Yan Zhang, Yi-Qing Zhang, De-Wei An, Yi-Bang Cheng, Song-Tao Tang, Min Liu, Jue Li, Jan A Staessen, Ji-Guang Wang, Yan Li

Objective: The optimal level of home blood pressure (HBP) for the prevention of cardiovascular complications is unknown. The Home Blood Pressure Intervention in the Community Trial (HomeBP, [NCT05858944]) is addressing this issue by randomising elderly hypertensive patients to standard or tight HBP control.

Methods and analysis: HomeBP is an investigator-initiated randomised clinical trial with open design and blinded endpoint evaluation. Eligible patients of either sex, aged 60-80 years, having uncontrolled home hypertension (≥135/85 mm Hg) after medication for at least 2 weeks will be recruited nationwide in China at up to 200 community healthcare centres. After stratification for centre and the presence of office hypertension (≥140/90 mm Hg), 10,000 patients will be randomised in a 1:1 proportion to a target HBP of 125-134/75-84 mm Hg or <125/75 mm Hg and followed up for 4 years. The primary outcome is a composite of cardiovascular death, non-fatal myocardial infarction, coronary revascularisation, unstable angina pectoris or heart failure requiring hospitalisation, and non-fatal stroke. Follow-up visits are scheduled monthly for 3 months after randomisation and 3-monthly thereafter. Patients record HBP for 7 consecutive days before every visit. A unique feature of the trial is the information technology setup, allowing the secure and instantaneous flow of HBP and other data to the study coordinating centre, where a standardised HBP report is generated. Hypertension specialists at Ruijin Hospital, Shanghai and at local tertiary hospitals provide treatment recommendations, which are transmitted to the caregivers at the community centres, who then fine-tune the treatment recommendations in a shared decision process with the patients to meet the values and clinical needs of the patients. Currently, 2281 patients have been randomised with no between-group differences in the baseline characteristics.

Trial registration number. URL: https://www.clinicaltrials.gov; Unique identifier: NCT05858944.

目标。预防心血管并发症的最佳家庭血压(HBP)水平尚不清楚。家庭血压干预社区试验(HomeBP, [NCT05858944])通过将老年高血压患者随机分配到标准或严格的血压控制组来解决这一问题。方法与分析。HomeBP是一项研究者发起的随机临床试验,采用开放设计和盲法终点评估。符合条件的60-80岁、服药至少2周后家庭高血压(≥135/85 mm Hg)不受控制的患者(男女不限)将在中国全国多达200个社区卫生保健中心招募。在中心分层和办公室高血压(≥140/90 mm Hg)存在后,10,000名患者将按1:1的比例随机分配到目标HBP为125-134/75-84 mm Hg或此后每月一次。患者在每次就诊前连续7天记录血压。该试验的一个独特之处在于信息技术设置,允许HBP和其他数据安全、即时地流向研究协调中心,在那里生成标准化的HBP报告。上海瑞金医院和当地三级医院的高血压专家提供治疗建议,这些建议被传递给社区中心的护理人员,然后他们在与患者共同决策的过程中微调治疗建议,以满足患者的价值和临床需求。目前,2281例患者已被随机分组,各组间基线特征无差异。试验注册号。URL: https://www.clinicaltrials.gov;唯一标识符:NCT05858944。
{"title":"A randomised trial comparing usual versus strict home blood pressure control in elderly patients with hypertension: protocol and initial progress.","authors":"Dong-Yan Zhang, Yi-Qing Zhang, De-Wei An, Yi-Bang Cheng, Song-Tao Tang, Min Liu, Jue Li, Jan A Staessen, Ji-Guang Wang, Yan Li","doi":"10.1080/08037051.2025.2472192","DOIUrl":"10.1080/08037051.2025.2472192","url":null,"abstract":"<p><strong>Objective: </strong>The optimal level of home blood pressure (HBP) for the prevention of cardiovascular complications is unknown. The Home Blood Pressure Intervention in the Community Trial (HomeBP, [NCT05858944]) is addressing this issue by randomising elderly hypertensive patients to standard or tight HBP control.</p><p><strong>Methods and analysis: </strong>HomeBP is an investigator-initiated randomised clinical trial with open design and blinded endpoint evaluation. Eligible patients of either sex, aged 60-80 years, having uncontrolled home hypertension (≥135/85 mm Hg) after medication for at least 2 weeks will be recruited nationwide in China at up to 200 community healthcare centres. After stratification for centre and the presence of office hypertension (≥140/90 mm Hg), 10,000 patients will be randomised in a 1:1 proportion to a target HBP of 125-134/75-84 mm Hg or <125/75 mm Hg and followed up for 4 years. The primary outcome is a composite of cardiovascular death, non-fatal myocardial infarction, coronary revascularisation, unstable angina pectoris or heart failure requiring hospitalisation, and non-fatal stroke. Follow-up visits are scheduled monthly for 3 months after randomisation and 3-monthly thereafter. Patients record HBP for 7 consecutive days before every visit. A unique feature of the trial is the information technology setup, allowing the secure and instantaneous flow of HBP and other data to the study coordinating centre, where a standardised HBP report is generated. Hypertension specialists at Ruijin Hospital, Shanghai and at local tertiary hospitals provide treatment recommendations, which are transmitted to the caregivers at the community centres, who then fine-tune the treatment recommendations in a shared decision process with the patients to meet the values and clinical needs of the patients. Currently, 2281 patients have been randomised with no between-group differences in the baseline characteristics.</p><p><p>Trial registration number. URL: https://www.clinicaltrials.gov; Unique identifier: NCT05858944.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2472192"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143490615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypertension and burden of myocardial infarction in China: risk factors, gender differences and temporal trends from a National Chronic Disease Surveillance study (2021-2023). 中国高血压和心肌梗死负担:来自国家慢性病监测研究(2021-2023)的危险因素、性别差异和时间趋势
IF 2.3 4区 医学 Pub Date : 2025-12-01 Epub Date: 2025-04-10 DOI: 10.1080/08037051.2025.2487584
Xiaoling Zhang, Dan Huang, Jianxun Zhao, Jinhui Wu

Background: Myocardial infarction (MI) remains a leading global cause of morbidity and mortality, with rising prevalence in China. Hypertension persists as a predominant modifiable risk factor. This study investigates MI prevalence, trends and risk factors using data from China CDC's Chronic Disease Surveillance program. Methods: Data from 258,742 participants (2021-2023) were analysed. Demographic characteristics, risk factors and gender/urban-rural disparities in MI prevalence were assessed. Multivariate logistic regression identified significant risk factors. Results: Hypertension was the leading MI risk factor (64.3%), followed by dyslipidaemia (58.6%) and smoking (42.3%). Men had higher MI prevalence than women (58.2% vs. 41.8%), and urban residents surpassed rural residents (56.7% vs. 43.3%), with significant lifestyle disparities (e.g. physical inactivity and smoking). Multivariate analysis identified age ≥ 60 years (OR = 2.75, 95% CI: 2.46-3.08), hypertension, dyslipidaemia, smoking and obesity (BMI ≥ 25) as key risk factors. MI incidence increased by 3.14% nationally from 2021 to 2023. Conclusions: China's MI burden is escalating, with notable gender, age and residence disparities. Older adults and individuals with hypertension, dyslipidaemia, smoking or obesity face elevated risks. Hypertension contributes to nearly two-thirds of MI cases, emphasising the urgency for targeted prevention strategies, particularly in high-risk groups (hypertensive individuals, older adults and urban populations).

背景:心肌梗死(MI)仍然是全球发病率和死亡率的主要原因,在中国患病率不断上升。高血压仍然是一个主要的可改变的危险因素。本研究利用中国疾病预防控制中心慢性病监测项目的数据调查心肌梗死的患病率、趋势和危险因素。方法:对来自258,742名参与者(2021-2023)的数据进行分析。评估心肌梗死患病率的人口统计学特征、危险因素和性别/城乡差异。多因素logistic回归确定了显著的危险因素。结果:高血压是心肌梗死的主要危险因素(64.3%),其次是血脂异常(58.6%)和吸烟(42.3%)。男性的心肌梗死患病率高于女性(58.2%对41.8%),城市居民超过农村居民(56.7%对43.3%),生活方式存在显著差异(如缺乏运动、吸烟)。多因素分析发现,年龄≥60岁(OR = 2.75, 95% CI:2.46-3.08)、高血压、血脂异常、吸烟和肥胖(BMI≥25)是关键危险因素。从2021年到2023年,全国心肌梗死发病率增加了3.14%。结论:中国的MI负担正在升级,性别、年龄和居住地差异显著。老年人和患有高血压、血脂异常、吸烟或肥胖的人面临更高的风险。高血压占心肌梗死病例的近三分之二,这强调了制定有针对性的预防策略的紧迫性,特别是在高危人群(高血压患者、老年人、城市人口)中。
{"title":"Hypertension and burden of myocardial infarction in China: risk factors, gender differences and temporal trends from a National Chronic Disease Surveillance study (2021-2023).","authors":"Xiaoling Zhang, Dan Huang, Jianxun Zhao, Jinhui Wu","doi":"10.1080/08037051.2025.2487584","DOIUrl":"10.1080/08037051.2025.2487584","url":null,"abstract":"<p><p><b>Background:</b> Myocardial infarction (MI) remains a leading global cause of morbidity and mortality, with rising prevalence in China. Hypertension persists as a predominant modifiable risk factor. This study investigates MI prevalence, trends and risk factors using data from China CDC's Chronic Disease Surveillance program. <b>Methods:</b> Data from 258,742 participants (2021-2023) were analysed. Demographic characteristics, risk factors and gender/urban-rural disparities in MI prevalence were assessed. Multivariate logistic regression identified significant risk factors. <b>Results:</b> Hypertension was the leading MI risk factor (64.3%), followed by dyslipidaemia (58.6%) and smoking (42.3%). Men had higher MI prevalence than women (58.2% <i>vs</i>. 41.8%), and urban residents surpassed rural residents (56.7% <i>vs.</i> 43.3%), with significant lifestyle disparities (e.g. physical inactivity and smoking). Multivariate analysis identified age ≥ 60 years (OR = 2.75, 95% CI: 2.46-3.08), hypertension, dyslipidaemia, smoking and obesity (BMI ≥ 25) as key risk factors. MI incidence increased by 3.14% nationally from 2021 to 2023. <b>Conclusions:</b> China's MI burden is escalating, with notable gender, age and residence disparities. Older adults and individuals with hypertension, dyslipidaemia, smoking or obesity face elevated risks. Hypertension contributes to nearly two-thirds of MI cases, emphasising the urgency for targeted prevention strategies, particularly in high-risk groups (hypertensive individuals, older adults and urban populations).</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2487584"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143794532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between smartphone screen time and exaggerated blood pressure response during treadmill exercise testing: a cross-sectional study. 在跑步机运动测试中,智能手机屏幕时间与夸大的血压反应之间的关系:一项横断面研究。
IF 2.3 4区 医学 Pub Date : 2025-12-01 Epub Date: 2025-07-20 DOI: 10.1080/08037051.2025.2533452
Muhammet Geneş, Cem Barçin

Objective: This study aimed to investigate the relationship between exaggerated hypertensive response to exercise (EHRE), mobile phone screen time and daily physical activity levels, with a focus on potential lifestyle-related factors that contribute to cardiovascular risk.

Methods: This observational case-control study enrolled 85 participants, who were categorised into an Exaggerated Hypertensive Response to Exercise (EHRE) group (n = 33) and a normotensive control group (n = 52). Participants underwent a standardised treadmill exercise test to identify EHRE. Objective data on daily mobile phone screen time and step counts were collected directly from the smartphones' native tracking applications.

Results: Compared to controls, participants with EHRE exhibited significantly higher daily mobile phone screen time (6.1 ± 1.2 h/day vs. 4.7 ± 0.9 h/day; p < .001), greater weekly screen time in dim-light conditions (e.g. in bed at night) (14.5 ± 3.4 h/week vs. 7.0 ± 2.1 h/week; p < .001), a longer duration of mobile phone usage (19.7 ± 1.9 years vs. 17.7 ± 1.5 years; p = .002) and notably lower daily step counts (4120 ± 950 steps/day vs. 6830 ± 1120 steps/day; p < .001).

Conclusion: Increased mobile phone screen time and reduced physical activity levels were significantly associated with EHRE, suggesting that these factors are relevant as modifiable behavioural risk factors. These findings support the integration of digital behavioural metrics into preventive cardiovascular risk management strategies.

目的:本研究旨在探讨高血压对运动的过度反应(EHRE)、手机屏幕使用时间和日常身体活动水平之间的关系,重点关注与心血管风险相关的潜在生活方式相关因素。方法:本观察性病例对照研究纳入了85名参与者,他们被分为运动后高血压反应过度组(EHRE) (n = 33)和正常血压对照组(n = 52)。参与者进行了标准化的跑步机运动测试以确定EHRE。每日手机屏幕时间和步数的客观数据直接从智能手机的原生跟踪应用程序中收集。结果:与对照组相比,EHRE参与者的每日手机屏幕时间显著增加(6.1±1.2小时/天vs. 4.7±0.9小时/天);p结论:手机屏幕时间的增加和身体活动水平的减少与EHRE显著相关,表明这些因素是可改变的行为风险因素。这些发现支持将数字行为指标整合到预防性心血管风险管理策略中。
{"title":"Association between smartphone screen time and exaggerated blood pressure response during treadmill exercise testing: a cross-sectional study.","authors":"Muhammet Geneş, Cem Barçin","doi":"10.1080/08037051.2025.2533452","DOIUrl":"10.1080/08037051.2025.2533452","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the relationship between exaggerated hypertensive response to exercise (EHRE), mobile phone screen time and daily physical activity levels, with a focus on potential lifestyle-related factors that contribute to cardiovascular risk.</p><p><strong>Methods: </strong>This observational case-control study enrolled 85 participants, who were categorised into an Exaggerated Hypertensive Response to Exercise (EHRE) group (<i>n</i> = 33) and a normotensive control group (<i>n</i> = 52). Participants underwent a standardised treadmill exercise test to identify EHRE. Objective data on daily mobile phone screen time and step counts were collected directly from the smartphones' native tracking applications.</p><p><strong>Results: </strong>Compared to controls, participants with EHRE exhibited significantly higher daily mobile phone screen time (6.1 ± 1.2 h/day vs. 4.7 ± 0.9 h/day; <i>p</i> < .001), greater weekly screen time in dim-light conditions (e.g. in bed at night) (14.5 ± 3.4 h/week vs. 7.0 ± 2.1 h/week; <i>p</i> < .001), a longer duration of mobile phone usage (19.7 ± 1.9 years vs. 17.7 ± 1.5 years; <i>p</i> = .002) and notably lower daily step counts (4120 ± 950 steps/day vs. 6830 ± 1120 steps/day; <i>p</i> < .001).</p><p><strong>Conclusion: </strong>Increased mobile phone screen time and reduced physical activity levels were significantly associated with EHRE, suggesting that these factors are relevant as modifiable behavioural risk factors. These findings support the integration of digital behavioural metrics into preventive cardiovascular risk management strategies.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2533452"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144641732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is the suppression index in adrenal venous sampling of the left adrenal vein a potentially sufficient criterion for adrenalectomy in primary aldosteronism patients with a right adrenal gland adenoma? 对于原发性醛固酮增多症合并右侧肾上腺腺瘤患者,左肾上腺静脉取样抑制指数是否可能成为肾上腺切除术的充分标准?
IF 2.3 4区 医学 Pub Date : 2025-12-01 Epub Date: 2025-10-10 DOI: 10.1080/08037051.2025.2571418
Joanna Kanarek-Kucner, Jarosław Kobiela, Łukasz Jędrzejewski, Anna Marszelewska, Tomasz Gorycki, Krzysztof Narkiewicz, Michał Hoffmann

Introduction: Catheterisation of the right adrenal vein during adrenal venous sampling (AVS) is technically challenging and may fail.

Purpose: We hypothesised that, in selected patients with primary aldosteronism who have a right adrenal gland adenoma on imaging, left-sided suppression on AVS could be sufficient to qualify the patient for successful surgical treatment.

Methods: We identified 77 patients referred to the Hypertension Inpatients Clinic at the Medical University of Gdańsk between 2015 and 2023 with suspected primary aldosteronism, subsequently confirmed by an intravenous saline suppression test. All patients underwent AVS, and management (surgical or pharmacological) was guided by the results. The effectiveness of surgical treatment was assessed by improvements in blood pressure control and reductions in serum aldosterone concentration.

Results: Of the 77 patients with confirmed primary aldosteronism, 13 (mean age 59.5 ± 10.1 years; 2 women) had a focal lesion in the right adrenal gland. In this subgroup, catheterisation of the right adrenal vein was unsuccessful in 4 patients (mean age 64.8 ± 6.5 years; 1 woman) due to anatomical factors; therefore, only the contralateral suppression index was calculated (mean 0.31). In view of their clinical histories and the right adrenal lesion on CT, all 4 patients were referred for adrenalectomy, and histology confirmed an aldosterone-producing adenoma. Following surgery, a significant decrease in serum aldosterone concentration (mean reduction 36.5 ± 18 ng/dL) and improved blood pressure control were observed.

Conclusion: In selected patients with primary aldosteronism - those with a typical right adrenal adenoma on CT and left-sided suppression on AVS- the suppression index may be considered a sufficient criterion for proceeding to adrenalectomy.

导言:在肾上腺静脉取样(AVS)期间,右肾上腺静脉导管置入在技术上具有挑战性,可能会失败。目的:我们假设,在选择的原发性醛固酮增多症患者中,影像学上有右侧肾上腺腺瘤,左侧AVS抑制足以使患者获得成功的手术治疗。方法:我们确定了2015年至2023年期间在Gdańsk医科大学高血压住院患者诊所就诊的77例疑似原发性醛固酮增多症患者,随后通过静脉生理盐水抑制试验确诊。所有患者都接受了AVS治疗,治疗(手术或药物)以结果为指导。通过血压控制的改善和血清醛固酮浓度的降低来评估手术治疗的有效性。结果:77例确诊原发性醛固酮增多症患者中,13例(平均年龄59.5±10.1岁;2例女性)右肾上腺局灶性病变。在该亚组中,4例患者(平均年龄64.8±6.5岁,1例女性)因解剖因素置管失败;因此,只计算对侧抑制指数(平均值0.31)。鉴于患者的临床病史及右侧肾上腺CT表现,4例患者均行肾上腺切除术,组织学证实为醛固酮分泌腺瘤。术后血清醛固酮浓度显著降低(平均降低36.5±18 ng/dL),血压控制得到改善。结论:在选定的原发性醛固酮增多症患者中,即CT表现为典型的右侧肾上腺腺瘤,AVS表现为左侧肾上腺抑制的患者,抑制指数可作为进行肾上腺切除术的充分标准。
{"title":"Is the suppression index in adrenal venous sampling of the left adrenal vein a potentially sufficient criterion for adrenalectomy in primary aldosteronism patients with a right adrenal gland adenoma?","authors":"Joanna Kanarek-Kucner, Jarosław Kobiela, Łukasz Jędrzejewski, Anna Marszelewska, Tomasz Gorycki, Krzysztof Narkiewicz, Michał Hoffmann","doi":"10.1080/08037051.2025.2571418","DOIUrl":"10.1080/08037051.2025.2571418","url":null,"abstract":"<p><strong>Introduction: </strong>Catheterisation of the right adrenal vein during adrenal venous sampling (AVS) is technically challenging and may fail.</p><p><strong>Purpose: </strong>We hypothesised that, in selected patients with primary aldosteronism who have a right adrenal gland adenoma on imaging, left-sided suppression on AVS could be sufficient to qualify the patient for successful surgical treatment.</p><p><strong>Methods: </strong>We identified 77 patients referred to the Hypertension Inpatients Clinic at the Medical University of Gdańsk between 2015 and 2023 with suspected primary aldosteronism, subsequently confirmed by an intravenous saline suppression test. All patients underwent AVS, and management (surgical or pharmacological) was guided by the results. The effectiveness of surgical treatment was assessed by improvements in blood pressure control and reductions in serum aldosterone concentration.</p><p><strong>Results: </strong>Of the 77 patients with confirmed primary aldosteronism, 13 (mean age 59.5 ± 10.1 years; 2 women) had a focal lesion in the right adrenal gland. In this subgroup, catheterisation of the right adrenal vein was unsuccessful in 4 patients (mean age 64.8 ± 6.5 years; 1 woman) due to anatomical factors; therefore, only the contralateral suppression index was calculated (mean 0.31). In view of their clinical histories and the right adrenal lesion on CT, all 4 patients were referred for adrenalectomy, and histology confirmed an aldosterone-producing adenoma. Following surgery, a significant decrease in serum aldosterone concentration (mean reduction 36.5 ± 18 ng/dL) and improved blood pressure control were observed.</p><p><strong>Conclusion: </strong>In selected patients with primary aldosteronism - those with a typical right adrenal adenoma on CT and left-sided suppression on AVS- the suppression index may be considered a sufficient criterion for proceeding to adrenalectomy.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2571418"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145237767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PM2.5-induced hypertension via renal GRK4/Nedd4L/ENaC axis: epigenetic and post-translational mechanisms. pm2.5通过肾GRK4/Nedd4L/ENaC轴诱导高血压:表观遗传和翻译后机制
IF 2.3 4区 医学 Pub Date : 2025-12-01 Epub Date: 2025-12-10 DOI: 10.1080/08037051.2025.2600133
Xi Lu, Te Yang, Jiahui Jiang, Tao Jiang, Dan Liu, Li Su, Yong Li

Background: Ambient fine particulate matter (PM2.5) is a major environmental risk factor for hypertension, yet the renal sodium-handling mechanisms remain incompletely understood. This study investigates the role of G protein-coupled receptor kinase 4 (GRK4) and its downstream signalling axis in PM2.5-induced hypertensive pathogenesis.

Methods: Male Sprague-Dawley rats were exposed to PM2.5 (10 or 40 mg/kg) via intratracheal instillation for 12 weeks. Hemodynamic parameters, renal function, and molecular alterations were analysed using immunohistochemistry, Western blot, qPCR, and co-immunoprecipitation. GRK4 expression was manipulated via lentiviral vectors to validate its role in blood pressure regulation.

Results: PM2.5 exposure induced dose-dependent hypertension, renal dysfunction, and sodium retention. Mechanistically, PM2.5 upregulated renal GRK4 expression through promoter hypomethylation, enhancing its interaction with Nedd4L (a ubiquitin ligase). Phosphorylated Nedd4L (p-Nedd4L) reduced epithelial sodium channel (ENaC) ubiquitination, leading to ENaC accumulation and sodium reabsorption. GRK4 overexpression exacerbated hypertension and sodium retention, whereas GRK4 knockdown attenuated these effects.

Conclusion: This study identifies a novel signalling axis-GRK4/Nedd4L/ENaC-in PM2.5-induced hypertension, highlighting epigenetic and post-translational regulatory mechanisms. These findings provide mechanistic insights into environmentally mediated hypertensive pathogenesis and suggest potential therapeutic targets for PM2.5-related cardiovascular diseases.

背景:环境细颗粒物(PM2.5)是高血压的主要环境危险因素,但肾脏钠处理机制尚不完全清楚。本研究探讨了G蛋白偶联受体激酶4 (GRK4)及其下游信号轴在pm2.5诱导的高血压发病中的作用。方法:雄性Sprague-Dawley大鼠气管内灌注PM2.5(10或40 mg/kg) 12周。使用免疫组织化学、Western blot、qPCR和共免疫沉淀分析血流动力学参数、肾功能和分子变化。通过慢病毒载体操纵GRK4表达,验证其在血压调节中的作用。结果:PM2.5暴露引起剂量依赖性高血压、肾功能障碍和钠潴留。在机制上,PM2.5通过启动子低甲基化上调肾脏GRK4的表达,增强其与Nedd4L(一种泛素连接酶)的相互作用。磷酸化的Nedd4L (p-Nedd4L)减少上皮钠通道(ENaC)泛素化,导致ENaC积累和钠重吸收。GRK4过表达加重了高血压和钠潴留,而GRK4敲低则减弱了这些作用。结论:本研究在pm2.5诱导的高血压中发现了一个新的信号轴grk4 /Nedd4L/ enact,突出了表观遗传和翻译后调控机制。这些发现为环境介导的高血压发病机制提供了机制见解,并提出了pm2.5相关心血管疾病的潜在治疗靶点。
{"title":"PM2.5-induced hypertension via renal GRK4/Nedd4L/ENaC axis: epigenetic and post-translational mechanisms.","authors":"Xi Lu, Te Yang, Jiahui Jiang, Tao Jiang, Dan Liu, Li Su, Yong Li","doi":"10.1080/08037051.2025.2600133","DOIUrl":"10.1080/08037051.2025.2600133","url":null,"abstract":"<p><strong>Background: </strong>Ambient fine particulate matter (PM2.5) is a major environmental risk factor for hypertension, yet the renal sodium-handling mechanisms remain incompletely understood. This study investigates the role of G protein-coupled receptor kinase 4 (GRK4) and its downstream signalling axis in PM2.5-induced hypertensive pathogenesis.</p><p><strong>Methods: </strong>Male Sprague-Dawley rats were exposed to PM2.5 (10 or 40 mg/kg) <i>via</i> intratracheal instillation for 12 weeks. Hemodynamic parameters, renal function, and molecular alterations were analysed using immunohistochemistry, Western blot, qPCR, and co-immunoprecipitation. GRK4 expression was manipulated <i>via</i> lentiviral vectors to validate its role in blood pressure regulation.</p><p><strong>Results: </strong>PM2.5 exposure induced dose-dependent hypertension, renal dysfunction, and sodium retention. Mechanistically, PM2.5 upregulated renal GRK4 expression through promoter hypomethylation, enhancing its interaction with Nedd4L (a ubiquitin ligase). Phosphorylated Nedd4L (p-Nedd4L) reduced epithelial sodium channel (ENaC) ubiquitination, leading to ENaC accumulation and sodium reabsorption. GRK4 overexpression exacerbated hypertension and sodium retention, whereas GRK4 knockdown attenuated these effects.</p><p><strong>Conclusion: </strong>This study identifies a novel signalling axis-GRK4/Nedd4L/ENaC-in PM2.5-induced hypertension, highlighting epigenetic and post-translational regulatory mechanisms. These findings provide mechanistic insights into environmentally mediated hypertensive pathogenesis and suggest potential therapeutic targets for PM2.5-related cardiovascular diseases.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2600133"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145686915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary aldosteronism in hypertensive patients with obstructive sleep apnea. 高血压阻塞性睡眠呼吸暂停患者原发性醛固酮增多症。
IF 2.3 4区 医学 Pub Date : 2025-12-01 Epub Date: 2025-05-20 DOI: 10.1080/08037051.2025.2507680
Zhe Hu, Xin Chen

Objective: To investigate the prevalence and clinical characteristics of primary aldosteronism (PA) in patients with hypertension and obstructive sleep apnoea (OSA) in a newly established cohort, given inconsistencies in previous studies and intolerance to drug washout in some cases.

Design and method: A single-centre cross-sectional study enrolled 316 hypertensive patients diagnosed with OSA via polysomnography. All participants underwent PA screening, followed by confirmatory testing for positive cases. Patients with confirmed PA underwent further subtype diagnosis and were assigned to the OSA and PA group. Those unable to undergo antihypertensive drug washout but with a high clinical suspicion of PA were categorised into the OSA and suspected PA group.

Results: Among 316 patients, 41 (13.0%) were PA. The prevalence was 4.8% in OSA alone, and 50.0% in OSA with hypokalaemia. Compared to the OSA group, the OSA and PA group had a lower proportion of current smokers, a longer duration of hypertension, lower serum triglycerides, lower serum potassium, higher plasma aldosterone concentration, urinary aldosterone excretion, and lower renin. Multivariable logistic regression showed that the diagnosis of PA in OSA patients was positively associated with hypertension duration, and negatively associated with serum potassium levels and smoking.

Conclusions: PA screening may be considered in patients with hypertension and OSA; however, given the relatively low prevalence in those with OSA alone, routine screening may not be cost-effective. In contrast, the presence of hypokalaemia was strongly associated with a higher prevalence of PA, suggesting that targeted screening is warranted in this subgroup.

目的探讨高血压合并阻塞性睡眠呼吸暂停(OSA)患者原发性醛固酮增多症(PA)的患病率及临床特征,分析以往研究结果的不一致性以及部分患者对药物洗脱期的不耐受。设计与方法单中心横断面研究纳入316例经多导睡眠图诊断为OSA的高血压患者。所有参与者都进行了PA筛查,随后对阳性病例进行了确认性检测。确认PA的患者进行进一步的亚型诊断,并被分配到OSA和PA组。不能进行降压药物洗脱,但临床怀疑PA高的患者分为OSA和怀疑PA组。结果316例患者中,PA 41例(13.0%)。OSA单独组患病率为4.8%,OSA合并低血钾组患病率为50.0%。与OSA组相比,OSA和PA组吸烟者比例较低,高血压持续时间较长,血清甘油三酯较低,血清钾较低,血浆醛固酮浓度较高,尿醛固酮排泄量较高,肾素较低。多变量logistic回归分析显示,OSA患者PA的诊断与高血压病程呈正相关,与血清钾水平和吸烟负相关。结论高血压合并OSA患者可考虑PA筛查;然而,考虑到OSA患者的患病率相对较低,常规筛查可能不具有成本效益。相比之下,低钾血症的存在与PA的高患病率密切相关,这表明在这一亚组中有必要进行靶向筛查。
{"title":"Primary aldosteronism in hypertensive patients with obstructive sleep apnea.","authors":"Zhe Hu, Xin Chen","doi":"10.1080/08037051.2025.2507680","DOIUrl":"10.1080/08037051.2025.2507680","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the prevalence and clinical characteristics of primary aldosteronism (PA) in patients with hypertension and obstructive sleep apnoea (OSA) in a newly established cohort, given inconsistencies in previous studies and intolerance to drug washout in some cases.</p><p><strong>Design and method: </strong>A single-centre cross-sectional study enrolled 316 hypertensive patients diagnosed with OSA <i>via</i> polysomnography. All participants underwent PA screening, followed by confirmatory testing for positive cases. Patients with confirmed PA underwent further subtype diagnosis and were assigned to the OSA and PA group. Those unable to undergo antihypertensive drug washout but with a high clinical suspicion of PA were categorised into the OSA and suspected PA group.</p><p><strong>Results: </strong>Among 316 patients, 41 (13.0%) were PA. The prevalence was 4.8% in OSA alone, and 50.0% in OSA with hypokalaemia. Compared to the OSA group, the OSA and PA group had a lower proportion of current smokers, a longer duration of hypertension, lower serum triglycerides, lower serum potassium, higher plasma aldosterone concentration, urinary aldosterone excretion, and lower renin. Multivariable logistic regression showed that the diagnosis of PA in OSA patients was positively associated with hypertension duration, and negatively associated with serum potassium levels and smoking.</p><p><strong>Conclusions: </strong>PA screening may be considered in patients with hypertension and OSA; however, given the relatively low prevalence in those with OSA alone, routine screening may not be cost-effective. In contrast, the presence of hypokalaemia was strongly associated with a higher prevalence of PA, suggesting that targeted screening is warranted in this subgroup.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2507680"},"PeriodicalIF":2.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144092660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Blood Pressure
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1